Compare Stocks: BHST, MED, WALD, and FTLF

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BHST BioHarvest Sciences	$1.75 -4.1%	$1.81	$1.37 ▼ $12.74	$35.70M	1.04	24,682 shs	19,557 shs
FTLF FitLife Brands	$8.67 -4.4%	$9.62	$8.50 ▼ $20.07	$85.18M	0.06	11,229 shs	18,931 shs
MED Medifast	$11.84 +1.5%	$11.92	$9.22 ▼ $13.58	$130.48M	0.68	119,576 shs	196,971 shs
WALD Waldencast	$0.87 -1.2%	$1.18	$0.72 ▼ $3.22	$111.75M	-0.1	379,154 shs	275,916 shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BHST BioHarvest Sciences	+11.66%	+22.97%	-1.62%	-36.14%	-85.44%
FTLF FitLife Brands	-1.73%	+0.55%	-1.52%	-17.99%	-54.99%
MED Medifast	+0.15%	+1.43%	-2.78%	+9.69%	-11.81%
WALD Waldencast	0.00%	0.00%	-33.66%	-49.18%	-53.78%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BHST BioHarvest Sciences	$1.75 -4.1%	$1.81	$1.37 ▼ $12.74	$35.70M	1.04	24,682 shs	19,557 shs
FTLF FitLife Brands	$8.67 -4.4%	$9.62	$8.50 ▼ $20.07	$85.18M	0.06	11,229 shs	18,931 shs
MED Medifast	$11.84 +1.5%	$11.92	$9.22 ▼ $13.58	$130.48M	0.68	119,576 shs	196,971 shs
WALD Waldencast	$0.87 -1.2%	$1.18	$0.72 ▼ $3.22	$111.75M	-0.1	379,154 shs	275,916 shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BHST BioHarvest Sciences	+11.66%	+22.97%	-1.62%	-36.14%	-85.44%
FTLF FitLife Brands	-1.73%	+0.55%	-1.52%	-17.99%	-54.99%
MED Medifast	+0.15%	+1.43%	-2.78%	+9.69%	-11.81%
WALD Waldencast	0.00%	0.00%	-33.66%	-49.18%	-53.78%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BHST BioHarvest Sciences	2.33	Hold	$6.50	272.49% Upside
FTLF FitLife Brands	3.00	Buy	$18.00	107.61% Upside
MED Medifast	1.67	Reduce	$12.00	1.35% Upside
WALD Waldencast	2.25	Hold	$2.33	168.51% Upside

Current Analyst Ratings Breakdown

Latest BHST, MED, WALD, and FTLF Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/6/2026	FTLF FitLife Brands	Zacks Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold ➝ Strong-Buy
10/2/2026	FTLF FitLife Brands	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Hold (C) ➝ Hold (C-)
9/21/2026	WALD Waldencast	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
9/17/2026	FTLF FitLife Brands	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Hold (C-) ➝ Hold (C)
9/14/2026	BHST BioHarvest Sciences	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Sell (D-)
9/1/2026	FTLF FitLife Brands	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Reiterated Rating	Hold (C-)
9/1/2026	WALD Waldencast	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Downgrade	Sell (D-) ➝ Sell (E+)
8/17/2026	MED Medifast	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D)
8/17/2026	WALD Waldencast	Weiss Ratings Subscribe to MarketBeat All Access to unlock brokerage rankings	Upgrade	Sell (E+) ➝ Sell (D-)
8/12/2026	BHST BioHarvest Sciences	Maxim Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Buy	$12.00 ➝ $5.00
8/12/2026	BHST BioHarvest Sciences	Roth Capital Subscribe to MarketBeat All Access to unlock brokerage rankings	Lower Price Target	Buy	$10.00 ➝ $8.00

(Data available from 10/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BHST BioHarvest Sciences	$34.51M	0.99	N/A	N/A	$1.30 per share	1.34
FTLF FitLife Brands	$81.46M	1.00	$1.09 per share	7.92	$4.65 per share	1.86
MED Medifast	$385.79M	0.34	$0.42 per share	28.00	$18.10 per share	0.65
WALD Waldencast	$272.07M	0.41	$0.06 per share	13.72	$3.90 per share	0.22

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BHST BioHarvest Sciences	-$11.14M	-$0.52	N/A	N/A	N/A	-31.21%	-58.30%	-25.60%	11/12/2026 (Estimated)
FTLF FitLife Brands	$6.33M	$0.62	13.89	6.72	N/A	6.15%	18.10%	7.63%	N/A
MED Medifast	-$18.67M	-$2.33	N/A	N/A	N/A	-8.08%	-6.69%	-5.25%	11/9/2026 (Estimated)
WALD Waldencast	-$229.75M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Latest BHST, MED, WALD, and FTLF Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/9/2026	Q3 2026	MED Medifast	-$0.35	N/A	N/A	N/A	$71.30 million	N/A
8/13/2026	Q2 2026	FTLF FitLife Brands	$0.18	$0.20	+$0.02	$0.20	N/A	$26.55 million
8/10/2026	Q2 2026	BHST BioHarvest Sciences	-$0.13	-$0.17	-$0.04	-$0.17	$9.45 million	$8.84 million
8/3/2026	Q2 2026	MED Medifast	-$0.65	-$0.28	+$0.37	-$0.28	$72.70 million	$76.38 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BHST BioHarvest Sciences	N/A	N/A	N/A	N/A	N/A
FTLF FitLife Brands	N/A	N/A	N/A	N/A	N/A
MED Medifast	N/A	N/A	-100.00%	N/A	N/A
WALD Waldencast	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BHST BioHarvest Sciences	N/A	2.24	1.75
FTLF FitLife Brands	0.67	1.46	0.45
MED Medifast	N/A	4.86	4.35
WALD Waldencast	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BHST BioHarvest Sciences	N/A
FTLF FitLife Brands	2.32%
MED Medifast	95.51%
WALD Waldencast	41.97%

Insider Ownership

Company	Insider Ownership
BHST BioHarvest Sciences	N/A
FTLF FitLife Brands	61.70%
MED Medifast	3.70%
WALD Waldencast	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BHST BioHarvest Sciences	89	19.62 million	N/A	N/A
FTLF FitLife Brands	81	9.39 million	3.60 million	Not Optionable
MED Medifast	380	11.18 million	10.77 million	Optionable
WALD Waldencast	367	128.60 million	N/A	Not Optionable

BHST, MED, WALD, and FTLF Headlines

Recent News About These Companies

Waldencast consensus price target lowered by 13.38% to $2.09

October 2, 2026 | msn.com

Waldencast plc Reports Earnings Results for the Half Year Ended June 30, 2026

September 29, 2026 | marketscreener.comM

Waldencast plc Announces First Half 2026 Financial Results

September 28, 2026 | globenewswire.com

Waldencast PLC (NASDAQ:WALD) Shares Shorted: Short Interest Up 374.1% in September

September 25, 2026 | marketbeat.com

Waldencast plc Files Form 25 to Voluntary Delist from Nasdaq and Deregister its Securities under the Exchange Act

September 24, 2026 | globenewswire.com

Waldencast (NASDAQ:WALD) Trading 1.8% Higher - What's Next?

September 16, 2026 | marketbeat.com

Waldencast plc Announces Intention to Voluntarily Delist from Nasdaq and Deregister its Securities under the Exchange Act

September 14, 2026 | globenewswire.com

WALDW Waldencast plc WT EXP 072727

August 6, 2026 | seekingalpha.com

Waldencast plc: Waldencast Announces Completion of the Sale of Obagi Medical to Bridgepoint

July 31, 2026 | finanznachrichten.de

Waldencast Announces Completion of the Sale of Obagi Medical to Bridgepoint

July 30, 2026 | globenewswire.com

Croma-Pharma Announces FDA Approval of Obagi saypha® ChIQ™ in the United States

July 1, 2026 | afp.comA

Waldencast plc: Obagi Medical Announces FDA Approval of Obagi saypha ChIQ Injectable Hyaluronic Acid Gel

June 17, 2026 | finanznachrichten.de

Waldencast Posts Flat 2025 Results as Obagi Surges, Launches Strategic Review and Deleveraging Drive

June 15, 2026 | theglobeandmail.com

Obagi Medical Announces FDA Approval of Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel

June 15, 2026 | globenewswire.com

Bridgepoint to Buy Obagi Medical from Waldencast

June 1, 2026 | marketwatch.com

Must read: Target's fashion revival strategy, Bridgepoint Group to acquire Obagi Medical

June 1, 2026 | msn.com

Waldencast Announces Sale of Obagi Medical to Bridgepoint

June 1, 2026 | globenewswire.com

Waldencast Stock Short Interest Report | NASDAQ:WALD | Benzinga

May 21, 2026 | benzinga.com

Waldencast PLC Class A WALD

May 16, 2026 | morningstar.comM

Obagi Medical Shares New Data on Recent Innovations at Music City Symposium for Cosmetic Advances & Laser Education (SCALE) Meeting

May 15, 2026 | globenewswire.com

Obagi and Next Health Partner to Launch “The Skin Recharge Station” Pop-Up Experience

May 14, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

BHST, MED, WALD, and FTLF Company Descriptions

BioHarvest Sciences NASDAQ:BHST

$1.74 -0.08 (-4.12%)

Closing price 03:55 PM Eastern

Extended Trading

$1.71 -0.04 (-2.01%)

As of 07:30 PM Eastern

BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.

FitLife Brands NASDAQ:FTLF

$8.67 -0.40 (-4.41%)

Closing price 04:00 PM Eastern

Extended Trading

$8.31 -0.36 (-4.19%)

As of 07:55 PM Eastern

FitLife Brands, Inc. provides nutritional supplements for health-conscious consumers in the United States and internationally. The company provides weight loss, sports nutrition, and general health products; sports nutrition products; weight loss and sports nutrition products; sports nutrition and general wellness formulations with an emphasis on natural, vegan, and organic ingredients; and male health and weight loss products, as well as other diet, health, and sports nutrition supplements and related products; and value-oriented sports nutrition and weight loss products. It offers MRC products which includes general health supplements; and natural skincare and beauty products. In addition, it markets its products under the brand names of NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Nutrology, Metis Nutrition, iSatori, BioGenetic Laboratories, Energize, Dr. Tobias, All-Natural Advice, and Maritime Naturals through franchised stores, as well as through retail locations, which include specialty, mass, and online. The company was formerly known as Bond Laboratories, Inc. and changed its name to FitLife Brands, Inc. in September 2013. FitLife Brands, Inc. was incorporated in 2005 and is headquartered in Omaha, Nebraska.

Medifast NYSE:MED

$11.84 +0.17 (+1.46%)

Closing price 03:59 PM Eastern

Extended Trading

$11.78 -0.06 (-0.52%)

As of 08:00 PM Eastern

Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

Waldencast NASDAQ:WALD

$0.87 -0.01 (-1.18%)

Closing price 10/2/2026

Extended Trading

$0.87 0.00 (0.00%)

As of 10/2/2026 07:30 PM Eastern

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians. The company also offers clean makeup products under the Milk Makeup brand. It sells its products to dermatologists, plastic surgeons, and other physicians who focuses on aesthetic and therapeutic skincare, including physicians on site at medical spas, through its direct sales force, as well as through distribution partners. The company is headquartered in White Plains, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BHST, MED, WALD, and FTLF Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BHST, MED, WALD, and FTLF Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BHST, MED, WALD, and FTLF Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

BHST, MED, WALD, and FTLF Company Descriptions

BioHarvest Sciences NASDAQ:BHST

FitLife Brands NASDAQ:FTLF

Medifast NYSE:MED

Waldencast NASDAQ:WALD

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest BHST, MED, WALD, and FTLF Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest BHST, MED, WALD, and FTLF Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

BHST, MED, WALD, and FTLF Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

BHST, MED, WALD, and FTLF Company Descriptions

BioHarvest Sciences NASDAQ:BHST

FitLife Brands NASDAQ:FTLF

Medifast NYSE:MED

Waldencast NASDAQ:WALD

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools